vs
Cytek Biosciences, Inc.（CTKB）与微策略（MSTR）财务数据对比。点击上方公司名可切换其他公司
微策略的季度营收约是Cytek Biosciences, Inc.的2.0倍（$123.0M vs $62.1M），Cytek Biosciences, Inc.同比增速更快（8.1% vs 1.9%），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 3.3%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Strategy Inc（原名为微策略）是1989年成立的美国上市企业，主营商业智能与移动软件业务，旗下产品可帮助企业分析内外部数据以支撑经营决策，还可用于移动应用开发，总部位于弗吉尼亚州泰森斯角，商业分析赛道核心竞品包括SAP等。
CTKB vs MSTR — 直观对比
营收规模更大
MSTR
是对方的2.0倍
$62.1M
营收增速更快
CTKB
高出6.2%
1.9%
两年增速更快
CTKB
近两年复合增速
3.3%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $123.0M |
| 净利润 | $-44.1M | — |
| 毛利率 | 52.9% | 66.1% |
| 营业利润率 | -9.0% | — |
| 净利率 | -70.9% | — |
| 营收同比 | 8.1% | 1.9% |
| 净利润同比 | -557.1% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBMSTR
| Q4 25 | $62.1M | $123.0M | ||
| Q3 25 | $52.3M | $128.7M | ||
| Q2 25 | $45.6M | $114.5M | ||
| Q1 25 | $41.5M | $111.1M | ||
| Q4 24 | $57.5M | $120.7M | ||
| Q3 24 | $51.5M | $116.1M | ||
| Q2 24 | $46.6M | $111.4M | ||
| Q1 24 | $44.9M | $115.2M |
净利润CTKBMSTR
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $2.8B | ||
| Q2 25 | $-5.6M | $10.0B | ||
| Q1 25 | $-11.4M | $-4.2B | ||
| Q4 24 | $9.6M | $-670.8M | ||
| Q3 24 | $941.0K | $-340.2M | ||
| Q2 24 | $-10.4M | $-102.6M | ||
| Q1 24 | $-6.2M | $-53.1M |
毛利率CTKBMSTR
| Q4 25 | 52.9% | 66.1% | ||
| Q3 25 | 52.7% | 70.5% | ||
| Q2 25 | 52.3% | 68.8% | ||
| Q1 25 | 48.6% | 69.4% | ||
| Q4 24 | 58.5% | 71.7% | ||
| Q3 24 | 56.3% | 70.4% | ||
| Q2 24 | 54.6% | 72.2% | ||
| Q1 24 | 51.3% | 74.0% |
营业利润率CTKBMSTR
| Q4 25 | -9.0% | — | ||
| Q3 25 | -17.6% | — | ||
| Q2 25 | -23.3% | — | ||
| Q1 25 | -36.1% | -5331.4% | ||
| Q4 24 | 5.2% | -842.1% | ||
| Q3 24 | -8.2% | -372.7% | ||
| Q2 24 | -18.3% | -179.7% | ||
| Q1 24 | -23.9% | -176.8% |
净利率CTKBMSTR
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 2164.1% | ||
| Q2 25 | -12.2% | 8752.7% | ||
| Q1 25 | -27.5% | -3797.2% | ||
| Q4 24 | 16.8% | -555.8% | ||
| Q3 24 | 1.8% | -293.1% | ||
| Q2 24 | -22.4% | -92.0% | ||
| Q1 24 | -13.8% | -46.1% |
每股收益（稀释后）CTKBMSTR
| Q4 25 | — | — | ||
| Q3 25 | — | $8.42 | ||
| Q2 25 | — | $32.60 | ||
| Q1 25 | — | $-16.49 | ||
| Q4 24 | — | $4.49 | ||
| Q3 24 | — | $-1.72 | ||
| Q2 24 | — | $-0.57 | ||
| Q1 24 | — | $-0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $2.3B |
| 总债务越低越好 | — | $8.2B |
| 股东权益账面价值 | $341.7M | $44.1B |
| 总资产 | $461.5M | $61.6B |
| 负债/权益比越低杠杆越低 | — | 0.19× |
8季度趋势，按日历期对齐
现金及短期投资CTKBMSTR
| Q4 25 | $90.9M | $2.3B | ||
| Q3 25 | $93.3M | $54.3M | ||
| Q2 25 | $75.5M | $50.1M | ||
| Q1 25 | $95.3M | $60.3M | ||
| Q4 24 | $98.7M | $38.1M | ||
| Q3 24 | $162.3M | $46.3M | ||
| Q2 24 | $177.9M | $66.9M | ||
| Q1 24 | $168.8M | $81.3M |
总债务CTKBMSTR
| Q4 25 | — | $8.2B | ||
| Q3 25 | — | $8.2B | ||
| Q2 25 | — | $8.2B | ||
| Q1 25 | — | $8.1B | ||
| Q4 24 | — | $7.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $3.8B | ||
| Q1 24 | — | $3.6B |
股东权益CTKBMSTR
| Q4 25 | $341.7M | $44.1B | ||
| Q3 25 | $378.6M | $52.3B | ||
| Q2 25 | $377.6M | $47.5B | ||
| Q1 25 | $379.6M | $32.2B | ||
| Q4 24 | $395.7M | $18.2B | ||
| Q3 24 | $385.5M | $3.8B | ||
| Q2 24 | $389.1M | $2.8B | ||
| Q1 24 | $392.6M | $2.4B |
总资产CTKBMSTR
| Q4 25 | $461.5M | $61.6B | ||
| Q3 25 | $494.9M | $73.6B | ||
| Q2 25 | $493.3M | $64.8B | ||
| Q1 25 | $482.6M | $43.9B | ||
| Q4 24 | $499.5M | $25.8B | ||
| Q3 24 | $491.2M | $8.3B | ||
| Q2 24 | $483.7M | $7.1B | ||
| Q1 24 | $492.1M | $6.4B |
负债/权益比CTKBMSTR
| Q4 25 | — | 0.19× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | — | 0.17× | ||
| Q1 25 | — | 0.25× | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBMSTR
| Q4 25 | $-771.0K | — | ||
| Q3 25 | $-3.9M | $-8.3M | ||
| Q2 25 | $108.0K | $-34.9M | ||
| Q1 25 | $-125.0K | $-2.4M | ||
| Q4 24 | $2.0M | $-17.3M | ||
| Q3 24 | $13.2M | $-41.0M | ||
| Q2 24 | $6.2M | $-23.3M | ||
| Q1 24 | $4.0M | $28.6M |
自由现金流CTKBMSTR
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | $-11.1M | ||
| Q2 25 | $-1.5M | $-37.0M | ||
| Q1 25 | $-974.0K | $-5.1M | ||
| Q4 24 | $1.1M | $-17.6M | ||
| Q3 24 | $12.2M | $-41.4M | ||
| Q2 24 | $5.2M | $-24.1M | ||
| Q1 24 | $3.4M | $27.0M |
自由现金流率CTKBMSTR
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | -8.6% | ||
| Q2 25 | -3.2% | -32.3% | ||
| Q1 25 | -2.3% | -4.6% | ||
| Q4 24 | 1.9% | -14.6% | ||
| Q3 24 | 23.7% | -35.7% | ||
| Q2 24 | 11.0% | -21.6% | ||
| Q1 24 | 7.6% | 23.5% |
资本支出强度CTKBMSTR
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | 2.2% | ||
| Q2 25 | 3.5% | 1.8% | ||
| Q1 25 | 2.0% | 2.5% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.0% | 0.4% | ||
| Q2 24 | 2.3% | 0.6% | ||
| Q1 24 | 1.3% | 1.3% |
现金转化率CTKBMSTR
| Q4 25 | — | — | ||
| Q3 25 | — | -0.00× | ||
| Q2 25 | — | -0.00× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
MSTR
暂无分部数据
